Omnicell (MEX:OMCL) Research & Development: MXN1,641 Mil (TTM As of Mar. 2026)


MEX:OMCL Omnicell Inc MEX:OMCL
65 GF Score
Price MXN761.16
GF Value MXN745.75
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Omnicell Research & Development?

Omnicell MEX:OMCL 65 Research & Development is MXN1,641 Mil as of Mar. 2026. GuruFocus rates MEX:OMCL with a GF Score™ of 65/100 and a GF Value™ of MXN745.75 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Omnicell's Research & Development for the three months ended in Mar. 2026 was MXN388 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN1,641 Mil.

Omnicell  (MEX:OMCL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Omnicell Research & Development Related Terms

Omnicell Research & Development Historical Data

* Premium members only.

The historical data trend for Omnicell's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omnicell Research & Development Chart

Omnicell Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,553.24 2,046.48 1,648.45 1,885.61 1,596.60

Omnicell Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 419.93 406.20 440.65 406.07 388.05
MEX:OMCL
65GF Score
Omnicell Inc MEX:OMCL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omnicell Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,641 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN1,641 Mil mean?
Omnicell (MEX:OMCL) has a Research & Development of MXN1,641 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Omnicell and its competitors.
Is Omnicell's Research & Development too high?
Omnicell's current Research & Development is MXN1,641 Mil. Overall, Omnicell has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Omnicell's Research & Development compare to TDOC and HTFL?
Omnicell's Research & Development of MXN1,641 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Omnicell and its competitors. Omnicell's current Research & Development is MXN1,641 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omnicell stock overvalued right now?
Based on GuruFocus' analysis, Omnicell (MEX:OMCL) is currently considered Fairly Valued. The stock's GF Value™ is MXN745.75, compared to a current price of MXN761.16 — trading 2.1% above its estimated fair value. The current Research & Development is MXN1,641 Mil. Omnicell's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Omnicell (MEX:OMCL), the current Research & Development is MXN1,641 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omnicell (MEX:OMCL) Overvalued in 2026?

Based on GuruFocus' analysis, Omnicell stock appears to be overvalued. The current stock price of MXN761.16 is trading 2.1% above its estimated GF Value™ of MXN745.75. GuruFocus considers Omnicell to be Fairly Valued.

Key valuation signals for MEX:OMCL:

  • Research & Development: MXN1,641 Mil
  • GF Value™: MXN745.75 vs. price of MXN761.16 (2.1% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the MEX:OMCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Omnicell Business Description

Other Exchanges OMCL:USAOC9:Germany
Address 4220 North Freeway, Fort Worth, TX, USA, 76137
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
65GF Score

Get the complete analysis for MEX:OMCL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN761.16
Price
MXN745.75
GF Value